The most important fact: 6L9.F stock rallied 2400.00% to €0.025 in after hours trading on XETRA on 18 Mar 2026, driven by a volume spike to 3,500.00 shares versus an average volume of 279.00. We saw the move after the close in Germany as traders digested liquidity and micro-cap dynamics. This report explains the trading surge, links the move to ViewRay, Inc.’s fundamentals, and flags short-term risks and upside, with price targets and a proprietary Meyka AI view.
After-hours move: 6L9.F stock high-volume spike
ViewRay, Inc. (6L9.F) traded on XETRA in Germany and recorded a sharp after-hours jump to €0.025, up 2400.00% from the prior close of €0.001. Volume of 3,500.00 represents a relative volume of 12.54, indicating outsized interest compared with the 50-day average of 279.00. The immediate trading driver appears to be short-duration liquidity and positioning rather than new corporate releases.
Fundamentals and valuation for 6L9.F stock
ViewRay operates in Healthcare, Medical – Devices, with trailing metrics that show a small-cap balance sheet and recurring losses. Latest EPS is -0.55 and reported PE is -0.05. Price-to-sales is 2.34, price-to-book is 0.06, and current ratio stands at 2.36, supporting short-term solvency. The company reports revenue per share 0.566 and cash per share 0.752. These figures indicate recovery potential but ongoing negative margins and R&D intensity.
Technical and trading profile for 6L9.F stock
Technically, the share sits far below longer-term averages: 50-day price average 0.319 and 200-day average 2.717. Day range was €0.001 to €0.025. The one-month change shows extreme volatility, with the dataset showing a +2400.00% 1M move but multi-month declines of -95.28% over 3 months. High relative volume and low absolute price increase the chance of rapid reversals and wide spreads on XETRA.
Meyka AI rating and model outlook for 6L9.F stock
Meyka AI rates 6L9.F with a score out of 100: 61.46 (B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects two scenario targets: a short-term model target of €0.10 (implied upside 300.00% vs current €0.025) and a 12-month scenario target of €0.50 (implied upside 1900.00%). Forecasts are model-based projections and not guarantees.
Risks, liquidity and sector context for 6L9.F stock
Risk is high: shares outstanding are 8,289,130,240.00, market cap approx €207,228,256.00, and year high/low are €4.600 / €0.0005, showing extreme price range. Debt-to-equity is 1.05 and interest coverage is negative, reflecting financial strain. The Healthcare, Medical – Devices sector average current ratio is 2.74, with average PE near 29.52; ViewRay’s negative margins contrast with sector averages, implying added execution risk for investors.
Trading strategy and actionable points for 6L9.F stock
For traders, the high relative volume and sub-euro price present short-term opportunity and high risk. We suggest monitoring bid-ask spreads on XETRA, limiting position size, and using stop limits. Buyers should wait for confirmed follow-through above €0.05 on volume above 10,000.00 shares. For longer-term investors, prioritize quarterly earnings, cash runway and order cadence from ViewRay’s MRIdian systems.
Final Thoughts
Key takeaways: 6L9.F stock spiked to €0.025 in after hours on XETRA on 18 Mar 2026 with heavy relative volume (3,500.00 vs 279.00), signalling a liquidity-driven move rather than clear fundamental news. Meyka AI rates the ticker 61.46 out of 100 (B, HOLD) and offers model targets at €0.10 (short-term) and €0.50 (12-month), implying 300.00% and 1900.00% upside versus the current price €0.025. These targets are scenario-based; they assume improved sales and margin recovery and are not guarantees. Given negative EPS (-0.55), negative operating margins, and a large share base, risk is material. Traders should prioritise tight risk controls and watch follow-on volume and any corporate updates. We use Meyka AI as an AI-powered market analysis platform to quantify the move, but this is not investment advice. For further company detail visit ViewRay’s website and the financial data source below.
FAQs
What caused the 6L9.F stock spike in after hours?
The spike was driven by very high relative volume versus average volume, suggesting liquidity and positioning factors. There was no confirmation of major corporate news; traders should watch for official ViewRay updates and sustained volume on XETRA.
What is Meyka AI’s view and rating on 6L9.F stock?
Meyka AI rates 6L9.F with a score out of 100 at 61.46 (B, HOLD). The grade balances benchmark and sector comparisons, financial metrics, forecasts, and consensus. This is informational and not investment advice.
What are realistic price targets for 6L9.F stock?
Meyka AI’s model scenarios show a short-term target of €0.10 and a 12-month target of €0.50, implying 300.00% and 1900.00% upside from €0.025. Forecasts are model projections and not guarantees.
How should traders manage risk on 6L9.F stock after hours?
Limit position size, use stop limits, and watch bid-ask spreads. Look for follow-through volume above 10,000.00 shares on XETRA and confirmation of corporate news before adding exposure.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)